Arthritis and Rheumatology

ISSN: 2326-5191
eISSN: 2326-5205
Publisher: Wiley

Publications (214)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution Relation of MRI-detected Structural Damage in the Patellofemoral Joint to Pain and Performance Based Function: The MOST Study (2019) Maxwell J, Neogi T, Crossley K, Macri E, White D, Guermazi A, Roemer F, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution Mobile Apps in Rheumatology: Review and Analysis Using the Mobile App Rating Scale (MARS) (2019) Knitza J, Tascilar K, Messner EM, Meyer M, Vossen D, Pulla A, Bosch P, et al. Conference contribution Visceral Fat Deposition Associated with Pain in Osteoarthritis (2019) Li S, Desai N, Neogi T, Schwartz A, Michael L, Wang N, Sun X, et al. Conference contribution Cluster-based Spondyloarthritis Phenotypes Defined at Baseline Are Predictive of Different Severity Outcomes at 5-Year in the DESIR Cohort (2019) Costantino F, Aegerter P, Molto A, Schett G, Breban M, D'Agostino MA Conference contribution Serum Calprotectin Is a Prognostic Marker for Drug-Free Remission in RA (2019) De Moel E, Rech J, Mahler M, Roth J, Schouffoer A, Ronday K, Huizinga T, et al. Conference contribution Identification of Circulating MicroRNA Signatures in Patients with Psoriasis and Psoriatic Arthritis to Develop Novel Strategies for Early Diagnosis of a Bone and Joint Involvement (2019) Haschka J, Simon D, Bayat S, Kleyer A, Kampylafka E, Muschitz C, Skalicky S, et al. Conference contribution BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo (2019) Ross R, Corinaldesi C, Migneco G, El-Sherbiny Y, Holmes S, Distler J, Mckimmie C, Del Galdo F Conference contribution No Difference in Treatment Continuation of Different Biologics in Elderly Patients > 70 Years Compared to Younger Patients <= 65 Years (2019) Strangfeld A, Krueger K, Manger B, Kneitz C, Zink A, Schaefer M Conference contribution